Mark S. Levine

2018

In 2018, Mark S. Levine earned a total compensation of $1.2M as General Counsel & Corporate Secretary at Flexion Therapeutics, a 42% decrease compared to previous year.

Compensation breakdown

Bonus$123,808
Option Awards$482,189
Salary$386,900
Stock Awards$185,910
Other$33,685
Total$1,212,492

Levine received $482.2K in option awards, accounting for 40% of the total pay in 2018.

Levine also received $123.8K in bonus, $386.9K in salary, $185.9K in stock awards and $33.7K in other compensation.

Rankings

In 2018, Mark S. Levine's compensation ranked 8,240th out of 14,244 executives tracked by ExecPay. In other words, Levine earned more than 42.2% of executives.

ClassificationRankingPercentile
All
8,240
out of 14,244
42nd
Division
Manufacturing
3,258
out of 5,762
44th
Major group
Chemicals And Allied Products
1,220
out of 2,125
43rd
Industry group
Drugs
1,020
out of 1,814
44th
Industry
Pharmaceutical Preparations
794
out of 1,388
43rd
Source: SEC filing on April 26, 2019.

Levine's colleagues

We found four more compensation records of executives who worked with Mark S. Levine at Flexion Therapeutics in 2018.

2018

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

2018

David Arkowitz

Flexion Therapeutics

Chief Financial Officer

2018

Neil Bodick

Flexion Therapeutics

Chief Scientific Officer

2018

Scott Kelly

Flexion Therapeutics

Chief Medical Officer

News

You may also like